We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Sarah Whelan, PhD

Sarah Whelan, PhD profile page

Science Writer

Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.

Got a Question for Sarah Whelan, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content
Total: 278
Antibodies in Screening infographic snippet

Antibodies in Screening

Download this infographic to learn more about therapeutic antibodies and their applications, the development of therapeutic antibodies and how high-throughput screening approaches and AI may enable antibody development.

An example of a Mediterranean-style salad.

Mediterranean Diet Linked to Lower Mortality for Cancer Survivors, Study Finds

Researchers have found that adhering to the Mediterranean diet – known for being rich in vegetables and whole grains and low in sugar and salt – can reduce the risk of mortality for cancer survivors.
A person pointing at and interpreting some brain scans.

New Alzheimer’s Drug Donanemab Approved by FDA

The drug donanemab (also known as Kisunla™) has been approved by the US Food and Drug Administration (FDA) for the treatment of adults with early symptomatic Alzheimer’s disease (AD).
Various cell types inside SemaCyte wells.
Industry Insight

Semarion Wins SLAS Europe Ignite Award 2024

At SLAS Europe 2024, Technology Networks had the pleasure of speaking with Jeroen Verheyen, CEO of Semarion, to discuss their award-winning work and how technological innovations advance research.
An illustration of the inside of the gut.

How Algae Microrobots Could Tackle Inflammatory Bowel Disease

University of California San Diego (UCSD) researchers have developed algae-based “microrobots” that reduce inflammatory bowel disease (IBD) symptoms in mouse models.
A person laying in bed wearing a CPAP mask for sleep apnea.

Antidiabetic Drug Tirzepatide Could Benefit Sleep Apnea Patients

A new clinical trial suggests that an antidiabetic drug, tirzepatide, could effectively treat obstructive sleep apnea (OSA). These data could pave the way to improved quality of life for people affected by the sleep-related disorder.
A glowing gold trophy.
Industry Insight

SLAS Europe 2024 New Product Award Winners

Two winners earned the New Product Award at SLAS Europe 2024: SEED Biosciences’ Dispen3D and Cryologyx’s PlateReady™. Technology Networks spoke with CEO of CryoLogyx Tom Congdon to learn more about their award-winning new product.
A person laying down.
Industry Insight

What FDA Approval of MDMA Could Mean for the Future of Psychedelic Therapy

To learn more about the FDA's pending decision on MDMA-assisted therapy for PTSD, Technology Networks interviewed Dr. Sam Clark, CEO of Terran Biosciences, who leads one of the industry’s largest psychedelic development programs.
Laboratory plastic waste.
Industry Insight

Tackling Plastic Waste for More Sustainable Science

At SLAS Europe 2024, Technology Networks had the pleasure of speaking with Tim Dillon, market manager (Nordics) at Mettler-Toledo Rainin, to learn about how more sustainable options can be implemented into scientists’ daily workflows.
Image of a microrobot made of an algae cell (green) covered with drug-filled nanoparticles (orange) coated with red blood cell membranes.

Algae-Based Microbots Deliver Cancer Drugs Directly to Lung Tumors

Combining biology and nanotechnology, researchers have developed algae-based “microbots” to deliver drugs directly to lung tumors in mice – with the approach showing promise for reducing tumor growth and increasing survival.